Article
'FLT3-ITD Mutation Does Not Influence Survival Outcome in Adult Acute Promyelocytic Leukemia Patients Treated With ATO and ATRA-Based Therapeutic Regimen: Experience From a North Indian Tertiary Care Centre'.
Clinical lymphoma, myeloma & leukemia - 1 Jun 2022
Deka Riju Rani, Naseem Shano, Bhatia Prateek, Binota Jogeshwar, Sonam Preeti, Rana Palak, Malhotra Pankaj, Varma Neelam
Abstract excerpt
INTRODUCTION: NPM1 and FLT3-ITD are frequently mutated genes in acute myeloid leukemia. We studied clinico-hematological profile and survival outcome of adult acute promyelocytic leukemia (APL) patients harboring these mutations. MATERIALS AND METHODS: De novo APL cases (> 12 years), enrolled between January 2019 and June 2020, were evaluated for FLT3-ITD and NPM1 mutations (A, B, D mutations) by conventional and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
